Journal of Cardiovascular Pharmacology

AUGUST 1, 2024

Thrombosis continues to pose a significant challenge in cardiovascular and cerebrovascular diseases, contributing to severe health complications such as myocardial infarction, acute ischemic stroke, and venous thromboembolism. In this paper, we comment the findings reported by Liu et al.

Cerebrovascular Disease 40

Cerebrovascular Disease Myocardial Infarction Thrombosis Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

This case was particularly challenging given the anatomical plausibility of parasagittal AVM/fistula given its midline location and venous drainage, considering the patient’s evident predisposition to systemic venous thrombosis hemorrhagic venous infarction mimicking lobar ICH is also possible.

Hemorrhage 40

Hemorrhage AFIB Cerebrovascular Disease Thrombosis 40

Stroke: Vascular and Interventional Neurology

AUGUST 26, 2024

Cerebrovascular complications occur in one fourth of patients with bacterial meningitis. The most common cerebrovascular disease complicating bacterial meningitis are cerebral infarctions (9%25%), intracerebral hemorrhage (1%7%), cerebral venous thrombosis (1%10%), and subarachnoid hemorrhage (1%5%).Streptococcus

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombosis Hemorrhage Outcomes 40

Stroke Journal

DECEMBER 9, 2024

Anticardiolipin antibodies, anti-2-glycoprotein I antibodies, and lupus anticoagulant were assessed using the guidelines of the International Society on Thrombosis and Haemostasis.RESULTS:aPL prevalence was 22% in patients with MMA and 25% in controls (P=0.74) with no differences in aPL subtypes between the 2 groups.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombosis Hemorrhage Stroke 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Frontiers in Cardiovascular Medicine

JANUARY 8, 2025

ObjectiveThis meta-analysis aims to evaluate the safety and efficacy of indobufen in the treatment of cardiovascular diseases, cerebrovascular diseases, and thromboembolic disorders. The primary focus is on the incidence of major adverse cardiovascular events (MACE), thrombosis, bleeding events, and adverse reactions.

Cerebrovascular Disease 52

Cerebrovascular Disease Cardiovascular Disease Myocardial Infarction Angina 52

Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.

Cardiovascular Disease 59

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Thrombosis 59